Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 3.00 | 98.75 | 0.0304 | -0.8218 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 2.00 | 98.75 | 0.0203 | -0.8654 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 62.00 | 98.75 | 0.6279 | 0.4492 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 66.00 | 98.75 | 0.6684 | 0.5133 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 125.00 | 98.75 | 1.2658 | 1.3544 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 36.27 | 108.00 | 98.75 | 1.0937 | 1.1279 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 156.25 | 36.27 | 78.00 | 98.75 | 0.7899 | 0.6988 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 156.25 | 36.27 | 176.00 | 98.75 | 1.7823 | 1.9835 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 156.25 | 36.27 | 93.00 | 98.75 | 0.9418 | 0.9187 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 156.25 | 36.27 | 165.00 | 98.75 | 1.6709 | 1.8531 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 156.25 | 36.27 | 99.00 | 98.75 | 1.0025 | 1.0035 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 156.25 | 36.27 | 109.00 | 98.75 | 1.1038 | 1.1415 |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 202.00 | 98.75 | 2.0456 | 2.2819 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 156.25 | 36.27 | 138.00 | 98.75 | 1.3975 | 1.5212 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 156.25 | 36.27 | 175.00 | 98.75 | 1.7722 | 1.9717 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 156.25 | 36.27 | 111.00 | 98.75 | 1.1241 | 1.1686 |